Szczepionka firmy Johnson & Johnson

EN_01465806_1176
Szczepionka firmy Johnson & Johnson
  • 30,00 EUR

    Making print for private purpose, storage in computer memory, no distribution rights.

  • 40,00 EUR

    Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.

  • 75,00 EUR

    Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.

  • 90,00 EUR

    Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices
Contact us to calculate price for another use. Prices only for online sales.
(FILES) A file photo taken on November 17, 2020 shows vials with Covid-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Johnson & Johnson. - The Johnson & Johnson vaccine is highly effective against severe Covid-19, including against the South African and Brazil variants, new documents released by the US Food and Drug Administration showed on February 24, 2021. In large clinical trials, the vaccine efficacy against severe disease was 85.9 percent in the United States, 81.7 percent in South Africa, and 87.6 percent in Brazil. (Photo by JUSTIN TALLIS / AFP)
2020-11-17
JUSTIN TALLIS/AFP/East News
AFP
JUSTIN TALLIS
AFP_93P37J
2,08MB
47cm x 31cm by 300dpi
17, 2020, 2021, 24, 6, 7, 81, 85, 87, 9, A, ADMINISTRATION, AFRICA, AFRICAN, AGAINST, AND, ATTACHED, BRAZIL, BY, CLINICAL, COMPANY, CORONAVIRUS, COVID-19, DISEASE, DOCUMENTS, DRUG, EFFECTIVE, EFFICACY, FEBRUARY, FILE, FILES, FOOD, HEALTH, HIGHLY, HORIZONTAL, ILLUSTRATION, IN, INCLUDING, INDUSTRY, IS, JOHNSON, JUSTIN, LARGE, LOGO, MEDICINE, NEW, NOVEMBER, OF, ON, PERCENT, PHARMACEUTICAL, RELEASED, SEVERE, SHOWED, SHOWS, SOUTH, STATES, STICKERS, SYRINGES, TAKEN, TALLIS, THE, TRIALS, UNITED, US, VACCINE, VARIANTS, VIALS, WAS, WITH,